- Introduction -
奇辉生物科技
 

L&G Biotechnology (Yangzhou) Co., Ltd. was co-founded by UK-educated Ph. D. , Dr. Zhenhui Gou and Qi Luo in 2019.

The company focuses on precise extraction technology of intestinal microflora and distributed AI system of intestinal microflora, including fully automated and standardized intestinal whole flora extraction equipment, remote interactive background quality management system, and an artificial intelligence analysis system combined with clinical.

The company is driven by independent innovation and has a team with rich experience in product development and scientific research, including PhD and masters in physics, medicine, machinery and electrical fields. We hold multiple Chinese invention and utility model patents (China Invention Patent;Patent No. ZL202111459600.0;ZL202210504029.8), and our core separation technology has obtained a European invention patent (EP3872163). It has the FMT Quality Research Center jointly established with Beijing 301 Hospital.

The company independently developed and has independent intellectual property rights of automatic, standardized intestinal flora extraction equipment. Internal comparative experiments indicate that the system maintains desirable microbial biodiversity and abundance under standard test conditions, enabling automated and standardized intestinal flora extraction. It supports the automated, standardized development of FMT-related technologies.

L&G Biotechnology (Yangzhou) Co., Ltd. is committed to building an integrated industrial platform for intestinal microecology. In 2019, it won the "Green Yang Jinfeng Entrepreneurial Talent Award" of Yangzhou City in the same year. In 2021, it won the title of outstanding enterprise in the 9th "Entrepreneurship Jiangsu" Science and Technology Entrepreneurship Competition in Jiangsu Province.In the same year, Dr. Gou Zhenhui, founder of the company, was selected as the "Double Innovation Talent" in Jiangsu Province in 2021 and has been awarded the title of Model Worker.In 2022, it was once again awarded the "Outstanding Enterprise" title at the 10th Jiangsu Province "Entrepreneurship Jiangsu" Science and Technology Entrepreneurship Competition. In 2025, it won the Third Prize at the HICOOL Global Entrepreneurship Competition.

- Culture -
Mission

Decoding the Microbiome, Shaping a Healthier Future

Vision

Striving to be a pioneer in the global microbiome field

Core Value

Innovation Priority, Quality Focus, Win-win Partnership, Service Excellence

Gou Zhenhui CEO

PhD in physics, Senior Member of the Royal Society of Physics, MBA;Successfully presided over the development of

Luo Qi Chairman

Biomedical experts;Years of successful business experience in the pharmaceutical field; Many years of pharmaceutical sales channels;Invention of Ecolith - intestinal microecological immune nutrition

- Qualifications -